Kaya Holdings (KAYS) Cash from Financing Activities (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Cash from Financing Activities of $25000.0 in Q3 2025, down 87.5% quarter-over-quarter from $200000.0 in Q2 2025, and down 90.0% on a YoY basis from $250000.0 in Q3 2024.
Kaya Holdings (KAYS) Cash from Financing Activities (2011 - 2025) Analysis & Trends
Kaya Holdings' Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $25000.0 for Q3 2025.
- In Q3 2025, Cash from Financing Activities fell 90.0% year-over-year to $25000.0; the TTM figure through Sep 2025 stood at $666607.0 (down 27.35% YoY), while the FY2024 annual figure was $1.0 million, up 309.84% from the prior year.
- Cash from Financing Activities was $25000.0 for Q3 2025 at Kaya Holdings, down from $200000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $378273.0 in Q2 2021 to a low of -$370000.0 in Q1 2023.
- Historically, Cash from Financing Activities has averaged $151881.7 across 5 years, with a median of $208750.0 in 2024.
- The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities soared 372.84% in 2021, then plunged 90.0% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$232273.0 in 2021, then soared by 194.72% to $220000.0 in 2022, then slipped by 27.27% to $160000.0 in 2023, then jumped by 54.13% to $246607.0 in 2024, then slumped by 89.86% to $25000.0 in 2025.
- The last three Cash from Financing Activities figures came in at $25000.0 (Q3 2025), $200000.0 (Q2 2025), and $195000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -86.10 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -11.62 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | -18.05 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Dec 31, 2024 | 246,607.00 |
| Dec 31, 2024 | 246,607.00 |
| Sep 30, 2024 | 250,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 217,500.00 |
| Mar 31, 2024 | 217,500.00 |
| Dec 31, 2023 | 160,000.00 |
| Dec 31, 2023 | 160,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 350,000.00 |